Dopamine receptor agonists and sleep disturbances in Parkinson's disease

K Ray Chaudhuri; Kartik Logishetty

doi:10.1016/S1353-8020(09)70845-4

Dopamine receptor agonists and sleep disturbances in Parkinson's disease

Parkinsonism Relat Disord. 2009 Dec:15 Suppl 4:S101-4. doi: 10.1016/S1353-8020(09)70845-4.

Authors

K Ray Chaudhuri¹, Kartik Logishetty

Affiliation

¹ National Parkinson Foundation Centre of Excellence, King's College Hospital, University Hospital Lewisham, London, UK. [email protected]

PMID: 20123546
DOI: 10.1016/S1353-8020(09)70845-4

Abstract

Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in Parkinson's disease (PD) while others may be precipitated. In this review, we discuss how dopamine receptor agonists can both ameliorate and aggravate the sleep problems in PD, a key non-motor symptom of this disease.

Publication types

Review

MeSH terms

Animals
Dopamine Agonists / adverse effects
Dopamine Agonists / therapeutic use*
Humans
Parkinson Disease / complications*
Parkinson Disease / drug therapy*
Parkinson Disease / physiopathology
Sleep Wake Disorders / drug therapy*
Sleep Wake Disorders / etiology*
Sleep Wake Disorders / physiopathology
Time Factors

Substances

Dopamine Agonists